Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy

British Journal of Ophthalmology

Volumn 80, Issue 3, 1996, Pages 241-245

  Pe'er, Jacob ^a   Folberg, Robert ^b   Itin, Ahuva ^c   Gnessin, Hadassah ^a   Hemo, Itzhak ^a   Keshet, Eli ^c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF IOWA   (United States)

^c HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CELL POPULATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENUCLEATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPOXIA; ISCHEMIA; MALE; NEOVASCULAR GLAUCOMA; NERVE CELL; PRIORITY JOURNAL; RETINA CELL; RETINA NEOVASCULARIZATION; SENSORY NERVE CELL; VITREOUS BODY;

EID: 0029920567     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.80.3.241     Document Type: Article

References (38)

1. Garner A. Ocular angiogenesis. Int J Exp Pathol 1986; 28: 249-309.
2. National Society to Prevent Blindness. Vision problems in the US. Data analysis, definitions, data sources, detailed data tables, analysis, interpretation. New York: National Society to Prevent Blindness, 1980.
3. Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1948; 65: 137-80.
4. Ashton N. Retinal vascularization in health and disease. Am J Ophthalmol 1957; 44: 7-17.
5. Grant M, Russell B, Fitzgerald C, Merimelt J. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization. Diabetes 1986; 35: 416-20.
6. King GL, Goodman AD, Buzney S, Moses A, Kahn CR. Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 1985; 75: 1028-36.
7. Siralingam A, Kenney J, Brown GC, Benson WE, Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1990; 108: 869-72.
8. Fredj-Reggrobelet D, Baudouin C, Negre F, Caruelle JP, Gastaud P, Lapalus P. Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy. Ophthalmic Res 1991; 23: 154-61.
9. Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy and retinal degeneration. Surv Ophthalmol 1992; 36: 373-84.
10. Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994; 118: 445-50.
11. Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, et al. Detection of vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994; 112: 1476-82.
12. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 33: 1480-7.
13. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-5.
14. Miller JW, Adamis AP, Shiima DT, D'Amore PA, Moultor RS, O'Reill MS, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994; 145: 574-84.
15. Pe'er J, Shweiki D, Itin A, Herno I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor (VEGF) by retinal cells is a common factor in neovascularizing ocular disease. Lab Invest 1995; 72: 638-45.
16. Addison DJ, Garner A, Ashton N. Degeneration of intramural pericytes in diabetic retinopathy. Br Med J 1970; 1: 264-6.
17. Ashton N. Vascular basement membrane changes in diabetic retinopathy. Br J Ophthalmol 1974; 58: 344-66.
18. Sebag J, McMeel JW. Diabetic retinopathy. Pathogenesis and the role of retina-derived growth factor in angiogenesis. Surv Ophthalmol 1986; 30: 377-84.
19. Wise GN. Retinal neovascularization. Trans Am Ophthalmol Soc 1956; 52: 729-826.
20. Chen CH, Chen SC. Angiogenic activity of vitreous and retinal extract. Invest Ophthalmol Vis Sci 1980; 19: 596-602.
21. Glazer BM, D'Amore PA, Michels RG, Patz Z, Fenselau A. Demonstration of vasoproliferative activity from mammalian retina. J Cell Biol 1980; 84: 298-304.
22. Lutty GA, Chandler C, Bennett A, Fait C, Patz A. Presence of endothelial cell growth factor activity in normal and diabetic eyes. Curr Eye Res 1986; 5: 9-17.
23. McIntosh LC, Gaal JC, Forrester JV. Serum-induced proliferation of retinal capillary endothelial cells is inhibited in the presence of retinal extract. Curr Eye Res 1989; 8: 871-81.
24. Bensaid M, Malecaze F, Bayard F, Tauber JP. Opposing effects of basic fibroblast growth factor and transforming growth factor-β on the proliferation of cultured bovine retinal capillary endothelial cells (BREC). Exp Eye Res 1989; 48: 791-9.
25. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of vascular endothelial mitogen produced by pituitary-derived follicule stellate cells. Proc Natl Acad Sci USA 1989; 86: 7311-5.
26. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309-12.
27. Connolly DT, Heuvelman DM, Nelson R, Olander J, Eppley B, Delfino JJ, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-8.
28. Leung DW, Cachianes G, Kaung WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-9.
29. Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 1989; 8: 3801-6.
30. Conn G, Soderman DD, Schaeffer MT, Wile M, Hatcher V, Thomas KA. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 1990; 87: 1323-7.
31. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev 1992; 13: 18-32.
32. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sortel A, et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 1991; 174: 1275-8.
33. Gartner S, Henkind P. Neovascularization of the iris (rubeosis iridis). Surv Ophthalmol 1978; 22: 291-312.
34. Rice TA, Michels RG, Maguir MG, Rice EF. The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy. Am J Ophthalmol 1983; 95: 1-11.
35. Poliner LS, Christianson DJ, Escoffery RF, Kolker AE, Gordon ME, Neovascular glaucoma after intracapsular and extracapsular cataract extraction in diabetic patients. Am J Ophthalmol 1985; 100: 637-43.
36. Little HL, Rosenthal AR, Dellaporta H, Jacobson DR. The effect of pan-retinal photocoagulation on rubeosis iridis. Am J Ophthalmol 1976; 81: 804-9.
37. Loatikainen L. Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and neovascular glaucoma. Br J Ophthalmol 1977; 61: 278-84.
38. Hayreh SS. Ocular neovascularization. An hypothesis. Int Ophthalmol 1980; 2: 27-32.